Skip to content

King Vision Video Laryngoscope Ambu (aBlade) System for Use in Children

King Vision Video Laryngoscope aBlade System for Use in Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02841189
Enrollment
100
Registered
2016-07-22
Start date
2014-12-31
Completion date
2017-11-07
Last updated
2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

King Vision Video Laryngoscope Intubation, Pediatric Anesthesia

Brief summary

This is a single center trial to evaluate the performance of the King Vision video laryngoscope in pediatric patients between the ages of one month and 10 years of age. If the performance is satisfactory, this device may become a standard laryngoscope for tracheal intubation in elective and emergent tracheal intubations.

Interventions

The King Vision video laryngoscope (Ambu) will be used for tracheal intubation.

Sponsors

King Systems Corporation
CollaboratorINDUSTRY
Indiana University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 10 Years
Healthy volunteers
No

Inclusion criteria

1. All children between the ages of 1 month to 10 years with a normal preoperative airway examination 2. Scheduled for a surgical procedure that requires tracheal intubation shall be included.

Exclusion criteria

1\. Patients that will be excluded are those with an airway examination or previous anesthesia history that suggests difficulty with mask ventilation.

Design outcomes

Primary

MeasureTime frameDescription
Ease of Endotracheal IntubationDuring intubationEase of endotracheal intubation

Countries

United States

Participant flow

Participants by arm

ArmCount
Participants
Participant details
100
Total100

Baseline characteristics

CharacteristicParticipants
Age, Categorical
<=18 years
100 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
100 participants
Sex: Female, Male
Female
45 Participants
Sex: Female, Male
Male
55 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 65
other
Total, other adverse events
0 / 65
serious
Total, serious adverse events
0 / 65

Outcome results

Primary

Ease of Endotracheal Intubation

Ease of endotracheal intubation

Time frame: During intubation

ArmMeasureValue (NUMBER)
Ease of Endotracheal Tube PassageEase of Endotracheal Intubation65 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026